ArticleMedicine2026
The effects of plasma protein levels on the risk of endometriosis: A Mendelian randomization study.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Endometriosis is a prevalent gynecologic disorder that significantly impacts women's health. However, its underlying pathogenesis remains unknown. This study aimed to ascertain causal associations between plasma protein levels and endometriosis using a Mendelian randomization (MR) design. Plasma protein genome-wide association studies (GWAS) data originating from the UK Biobank Pharma Proteomics Project (UKB-PPP) were utilized as exposure variables. Endometriosis GWAS data from the FinnGen study and UKB study served as outcome variables at the discovery and replication stages, respectively. Summary-data-based MR (SMR) and instrument-dependent heterogeneity (HEIDI) tests were conducted to further validate the relationships between proteins and the risk of endometriosis. Genetic variations between the identified plasma proteins and endometriosis were investigated by colocalization analyses. The proteome‑wide MR and SMR results revealed that genetically predicted plasma levels of proteins (RSPO3, WASHC3, FSHB, and VEGFB) were positively associated with the risk of endometriosis. Among them, only FSHB and RSPO3 passed the HEIDI tests, and colocalization analyses further supported their causal relationship with endometriosis. Based on large-scale population GWAS data, our research demonstrated causal correlations of FSHB and RSPO3 with the risk of endometriosis. These findings suggest that plasma proteins are involved in the development of endometriosis and may serve as potential biomarkers and therapeutic targets for this complicated disease in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.